EA199700213A1 - Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений - Google Patents

Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений

Info

Publication number
EA199700213A1
EA199700213A1 EA199700213A EA199700213A EA199700213A1 EA 199700213 A1 EA199700213 A1 EA 199700213A1 EA 199700213 A EA199700213 A EA 199700213A EA 199700213 A EA199700213 A EA 199700213A EA 199700213 A1 EA199700213 A1 EA 199700213A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cream
subject
treatment
overview
water
Prior art date
Application number
EA199700213A
Other languages
English (en)
Other versions
EA000566B1 (ru
Inventor
Майкл П. Аллан
Original Assignee
Интернэшэнл Медикл Иноувэйшнз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Интернэшэнл Медикл Иноувэйшнз, Инк. filed Critical Интернэшэнл Медикл Иноувэйшнз, Инк.
Publication of EA199700213A1 publication Critical patent/EA199700213A1/ru
Publication of EA000566B1 publication Critical patent/EA000566B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Предметом изобретения является стабильный однородный крем на водной основе, содержащий нитроглицерин, ускоритель пенетрации, воду, загуститель и эмульгатор. Также предметом изобретения являются способ изготовления крема и его применения для лечения эректильной дисфункции у мужчин и женского аноргазма. Настоящее изобретение также относится к лечению пациентов, страдающих микроваскулярными заболеваниями или имеющих повреждения тканей.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199700213A 1995-03-06 1996-03-05 Стабильный однородный крем на основе нитроглицерина для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений EA000566B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39887295A 1995-03-06 1995-03-06
US08/594,304 US5698589A (en) 1993-06-01 1996-01-30 Water-based topical cream containing nitroglycerin and method of preparation and use thereof
PCT/US1996/002989 WO1996027372A1 (en) 1995-03-06 1996-03-05 Water-based topical cream containing nitroglycerin; method of preparation and use thereof

Publications (2)

Publication Number Publication Date
EA199700213A1 true EA199700213A1 (ru) 1998-02-26
EA000566B1 EA000566B1 (ru) 1999-12-29

Family

ID=27016409

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199700213A EA000566B1 (ru) 1995-03-06 1996-03-05 Стабильный однородный крем на основе нитроглицерина для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений

Country Status (22)

Country Link
US (1) US5698589A (ru)
EP (1) EP0814800B1 (ru)
JP (1) JPH11501629A (ru)
KR (1) KR19980702766A (ru)
CN (1) CN1139380C (ru)
AP (1) AP691A (ru)
AT (1) ATE209895T1 (ru)
AU (1) AU701328B2 (ru)
BR (1) BR9607974A (ru)
CZ (1) CZ281897A3 (ru)
DE (1) DE69617654T2 (ru)
EA (1) EA000566B1 (ru)
HK (1) HK1005359A1 (ru)
HU (1) HUP9801234A3 (ru)
NO (1) NO974075L (ru)
NZ (1) NZ305095A (ru)
OA (1) OA10504A (ru)
PL (1) PL322110A1 (ru)
SI (1) SI9620038A (ru)
SK (1) SK117597A3 (ru)
TR (1) TR199700909T1 (ru)
WO (1) WO1996027372A1 (ru)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
GB2325855B (en) * 1997-06-04 2001-08-29 Healthscene Ltd Preparation for topical application to the male sexual organ
EP1535611A3 (en) * 1997-06-23 2009-09-16 Strakan International Limited Microdose therapy of vascular conditions by no donors
EP0998274B1 (en) 1997-06-23 2006-01-18 Cellegy Pharmaceuticals, Inc Microdose therapy of vascular conditions by no donors
WO1999002147A1 (en) 1997-07-09 1999-01-21 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US6593369B2 (en) 1997-10-20 2003-07-15 Vivus, Inc. Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US20050070516A1 (en) * 1997-10-28 2005-03-31 Vivus Inc. As-needed administration of an androgenic agent to enhance female desire and responsiveness
WO1999021562A1 (en) 1997-10-28 1999-05-06 Asivi, Llc Treatment of female sexual dysfunction
US20040014761A1 (en) * 1997-10-28 2004-01-22 Place Virgil A. Treatment of female sexual dysfunction with phosphodiesterase inhibitors
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
GB9802078D0 (en) * 1998-01-30 1998-03-25 Futura Medical Limited Preparation for treatment of erectile dysfunction
WO1999062533A1 (en) * 1998-06-04 1999-12-09 Jedco Products, Llc Preparation for topical application to the male sexual organ
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction
GB9818524D0 (en) * 1998-08-25 1998-10-21 Futura Medical Limited Inorgasmia treatment
IT1303793B1 (it) * 1998-11-27 2001-02-23 Promefarm S R L "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)"
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
AU2001261244B2 (en) * 2000-05-09 2006-08-03 Nitromed, Inc. Infrared thermography and methods of use
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
ATE369868T1 (de) * 2000-06-27 2007-09-15 Qualilife Pharmaceuticals Inc Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
HUP0002628A2 (en) * 2000-07-14 2002-06-29 Keri Pharma Kft Pharmaceutical combinations for treating diabetes
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
TR200300776T2 (tr) * 2000-08-30 2005-10-21 Unimed Pharmaceuticals, Inc. Erkeklerde cinsel organ sertleşmemesinin tedavi edilmesi ve libidonun arttırılması için yöntem.
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
CA2440141A1 (en) * 2001-03-06 2002-09-12 Cellegy Pharmaceuticals, Inc. Compounds and methods for the treatment of urogenital disorders
JP2003040763A (ja) * 2001-05-23 2003-02-13 Taisho Pharmaceut Co Ltd 多価アルコール含有軟膏剤基剤
SE0103528D0 (sv) * 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
KR20040082431A (ko) * 2002-02-15 2004-09-24 넥스메드 홀딩스 인코포레이티드 발기기능장애를 치료하기 위한 프로스타글란딘 조성물
AR036970A1 (es) * 2002-03-15 2004-10-20 Unimed Pharmaceuticals Inc Composicion farmaceutica androgenica y metodo para el tratamiento de la depresion
KR20050074896A (ko) * 2002-03-15 2005-07-19 유니메드 파마슈티칼스, 인크. 우울증 치료용 안드로겐 제약 조성물 및 방법
US8012472B2 (en) * 2002-12-23 2011-09-06 William Marsh Rice University Compositions and methods for suppressing fibrocytes
JP4819364B2 (ja) * 2002-12-23 2011-11-24 ウイリアム、マーシュ、ライス、ユーニヴァーサティ 線維細胞形成阻害の検出方法、ならびに線維細胞形成を増強する方法および化合物
US7763256B2 (en) * 2002-12-23 2010-07-27 William Marsh Rice University Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
US20100297074A1 (en) * 2002-12-23 2010-11-25 Richard Hans Gomer Wound healing compositions, systems, and methods
US20050031699A1 (en) 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
GB0417675D0 (en) * 2004-08-09 2004-09-08 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
AU2005307736A1 (en) * 2004-11-17 2006-05-26 Lindsey Berkson Composition and method for facilitating the healing of non-healing and slow-healing wounds and ulcerations
US20060127483A1 (en) * 2004-12-10 2006-06-15 Alan Drizen Topical drug delivery system
GB0602224D0 (en) * 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
US8247370B2 (en) * 2006-12-04 2012-08-21 Promedior, Inc. Conjoint therapy for treating fibrotic diseases
US9884899B2 (en) * 2007-07-06 2018-02-06 Promedior, Inc. Methods for treating fibrosis using CRP antagonists
US8497243B2 (en) * 2007-07-06 2013-07-30 Promedior, Inc. Methods and compositions useful in the treatment of mucositis
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
DE202008007318U1 (de) * 2008-03-14 2008-07-31 G. Pohl-Boskamp Gmbh & Co. Kg Langzeitstabile pharmazeutische Zubereitung mit dem Wirkstoff Glyceroltrinitrat
US20100263675A1 (en) * 2009-04-21 2010-10-21 Ansell Healthcare Products Llc Condom with Localized Active Agent
US20100035929A1 (en) * 2008-06-09 2010-02-11 Lindsley Craig W Unnatural dispyrin analogues, preparation and uses thereof
WO2010011650A1 (en) * 2008-07-21 2010-01-28 Imi International Medical Innovations (D/B/A Procris Pharmaceuticals) Stable water-based topical pharmaceutical creams and methods of making and using same
WO2010057117A2 (en) * 2008-11-14 2010-05-20 Helm Pharmaceuticals, Inc. Topical transdermal drug delivery compositions
JP5797565B2 (ja) * 2009-03-11 2015-10-21 プロメディオール， インコーポレイテッド 過敏性障害（ｈｙｐｅｒｓｅｎｓｉｔｉｖｅ ｄｉｓｏｒｄｅｒ）に対する処置および診断方法
CA2755047C (en) * 2009-03-11 2018-12-04 Promedior, Inc. Treatment methods for autoimmune disorders
UA110323C2 (en) * 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
ES2552793T3 (es) 2009-06-17 2015-12-02 Promedior Inc. Variantes de SAP y su uso
WO2011057386A1 (en) * 2009-11-13 2011-05-19 Oral Delivery Technology Ltd. Composition and prophylactic device for enhancing sexual performance or pleasure
EP2600837A1 (en) 2010-08-03 2013-06-12 G. Pohl-Boskamp GmbH & Co. KG Use of glyceryl trinitrate for treating hematomas
PL2678000T3 (pl) 2011-02-25 2018-08-31 G. Pohl-Boskamp Gmbh & Co. Kg Stabilizowane granulaty zawierające triazotan glicerolu
PL2668947T3 (pl) 2012-05-31 2017-06-30 G. Pohl-Boskamp Gmbh & Co. Kg Indukcja arteriogenezy donorem NO, takim jak nitrogliceryna
US9248099B2 (en) 2012-05-31 2016-02-02 Desmoid Aktiengesellschaft Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
EP2878310B1 (en) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーＯｎｑｕａｌｉｔｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｈｉｎａ Ｌｔｄ． Ｅｇｆｒ阻害に関連する疾患を予防又は治療する方法
AU2019254237A1 (en) 2018-04-16 2020-12-03 Onquality Pharmaceuticals China Ltd. Method for preventing or treating side effects of cancer therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4336243A (en) * 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5001151A (en) * 1987-08-11 1991-03-19 Fujisawa Usa, Inc. Aqueous nitroglycerin injection and manufacturing process
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof

Also Published As

Publication number Publication date
ATE209895T1 (de) 2001-12-15
OA10504A (en) 2002-04-24
AP9701068A0 (en) 1997-10-31
NO974075L (no) 1997-10-27
WO1996027372A1 (en) 1996-09-12
SK117597A3 (en) 1998-01-14
AU5302596A (en) 1996-09-23
EP0814800A4 (en) 1998-07-01
DE69617654D1 (de) 2002-01-17
PL322110A1 (en) 1998-01-05
EP0814800A1 (en) 1998-01-07
HUP9801234A3 (en) 2000-07-28
EA000566B1 (ru) 1999-12-29
TR199700909T1 (xx) 1998-02-21
AU701328B2 (en) 1999-01-28
SI9620038A (sl) 1998-04-30
US5698589A (en) 1997-12-16
AP691A (en) 1998-10-12
EP0814800B1 (en) 2001-12-05
KR19980702766A (ko) 1998-08-05
DE69617654T2 (de) 2002-08-08
HUP9801234A2 (hu) 1999-01-28
CN1139380C (zh) 2004-02-25
BR9607974A (pt) 1998-01-13
JPH11501629A (ja) 1999-02-09
CN1177294A (zh) 1998-03-25
CZ281897A3 (en) 1997-12-17
HK1005359A1 (en) 1999-01-08
NZ305095A (en) 2005-05-27
NO974075D0 (no) 1997-09-04

Similar Documents

Publication Publication Date Title
EA199700213A1 (ru) Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений
ATE338554T1 (de) Pharmazeutische zusammensetzungen zur behandlung von erektiler dysfunktion
UY23665A1 (es) Procedimiento para la preparacion de compuesto farmaceutico
DE69332713D1 (de) Verwendung von Histamine-2 Agonisten zur Behandlung sexueller Funktionsstörungen
HUP0004347A2 (hu) Vegyületek női szexuális diszfunkció kezelésére
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
ES2164916T3 (es) Tratamiento de la esclerosis multiple.
HUP0400548A2 (hu) Belső szemnyomást csökkentő hatóanyag-kombinációk alkalmazása glaukoma kezelésére szolgáló gyógyszerkészítmények előállítására
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
ATE303818T1 (de) Verwendung des vaskularen endothelialen wachstumsfaktors zur behandlung von erektilen dysfunktionen
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
CA2158425A1 (en) Diagnostic and treatment of erectile dysfunction
ATE203680T1 (de) Konjugat zur behandlung von entzündungserkrankungen
BE904223A (fr) Association renfermant a titre de principes actifs, un analgesique central et l'adenine.
CA2214418A1 (en) Water-based topical cream containing nitroglycerin; method of preparation and use thereof
EA199700034A2 (ru) Способ в.г.соломатова коррекции энергетического состояния живого существа
ATE218869T1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
DE60134656D1 (de) Hilfsmittel und methoden zur transdermalen applikation von felodipin
MD686F1 (en) Method of esophageal reflux treatment
UA30460A (ru) Способ лечения системного аутоиммунного заболевания
EA004801B1 (ru) Способ лечения болезни пейрони
UA36252A (ru) Способ определения соматической индивидуальности больного для выбора адекватной терапии
BG103988A (en) Local aphrodisiac

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU